Open AccessDosimetric evaluation of synthetic CT generated with GANs for MRI‐only proton therapy treatment planning of brain tumors
Author(s) -
Kazemifar Samaneh,
Barragán Montero Ana M.,
Souris Kevin,
Rivas Sara T.,
Timmerman Robert,
Park Yang K.,
Jiang Steve,
Geets Xavier,
Sterpin Edmond,
Owrangi Amir
Publication year - 2020
Publication title -
journal of applied clinical medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 48
ISSN - 1526-9914
DOI - 10.1002/acm2.12856
Subject(s) - proton therapy , radiation treatment planning , nuclear medicine , medicine , monte carlo method , pencil (optics) , radiology , radiation therapy , mathematics , physics , statistics , quantum mechanics
Purpose The purpose of this study was to address the dosimetric accuracy of synthetic computed tomography (sCT) images of patients with brain tumor generated using a modified generative adversarial network (GAN) method, for their use in magnetic resonance imaging (MRI)‐only treatment planning for proton therapy. Methods Dose volume histogram (DVH) analysis was performed on CT and sCT images of patients with brain tumor for plans generated for intensity‐modulated proton therapy (IMPT). All plans were robustly optimized using a commercially available treatment planning system (RayStation, from RaySearch Laboratories) and standard robust parameters reported in the literature. The IMPT plan was then used to compute the dose on CT and sCT images for dosimetric comparison, using RayStation analytical (pencil beam) dose algorithm. We used a second, independent Monte Carlo dose calculation engine to recompute the dose on both CT and sCT images to ensure a proper analysis of the dosimetric accuracy of the sCT images. Results The results extracted from RayStation showed excellent agreement for most DVH metrics computed on the CT and sCT for the nominal case, with a mean absolute difference below 0.5% (0.3 Gy) of the prescription dose for the clinical target volume (CTV) and below 2% (1.2 Gy) for the organs at risk (OARs) considered. This demonstrates a high dosimetric accuracy for the generated sCT images, especially in the target volume. The metrics obtained from the Monte Carlo doses mostly agreed with the values extracted from RayStation for the nominal and worst‐case scenarios (mean difference below 3%). Conclusions This work demonstrated the feasibility of using sCT generated with a GAN‐based deep learning method for MRI‐only treatment planning of patients with brain tumor in intensity‐modulated proton therapy.